Infusion of donor lymphocytes
Sponsors
Dana-Farber Cancer Institute, Wake Forest University Health Sciences
Conditions
Hematologic MalignancyImmunodeficiency
Phase 1
Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant
CompletedNCT00476177
Start: 2003-07-31End: 2009-07-31Updated: 2012-03-29
Donor Lymphocyte Infusion After Alternative Donor Transplantation
TerminatedNCT01027702
Start: 2009-08-31End: 2016-11-30Updated: 2022-04-22